CVS240816P54000
- 0.28
- +0.11+64.71%
CVS Health Newsroom
CVS Health Analyst Ratings
Wells Fargo Adjusts Price Target on CVS Health to $61 From $60, Maintains Equalweight Rating
Hold Rating on CVS Health Amidst Anticipated Earnings Pressure and Segment Challenges
CVS Health Price Target Cut to $63.00/Share From $64.00 by Deutsche Bank
HSBC Adjusts Price Target on CVS Health to $61 From $62
Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)
CVS Health (CVS) Gets a Buy From Evercore ISI
TD Cowen Remains a Hold on CVS Health (CVS)
Barclays Adjusts Price Target on CVS Health to $63 From $65
CVS Health Analyst Ratings
CVS Health: Hold Rating Justified by Mixed Financial Performance and Leadership Changes
CVS Health: A Buy Rating Backed by Strong Earnings Performance and Strategic Initiatives
Barclays Maintains CVS Health(CVS.US) With Hold Rating, Maintains Target Price $65
Barclays Remains a Hold on CVS Health (CVS)
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)
Cantor Fitzgerald Sticks to Its Hold Rating for CVS Health (CVS)
CVS Health Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)
CVS Health (CVS) Receives a Buy From Evercore ISI